Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1987 1
1990 1
1999 1
2001 3
2002 2
2003 3
2004 5
2005 11
2006 12
2007 6
2008 8
2009 14
2010 15
2011 9
2012 10
2013 11
2014 10
2015 10
2016 13
2017 12
2018 7
2019 10
2020 9
2021 21
2022 15
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial.
Soileau MJ, Aldred J, Budur K, Fisseha N, Fung VS, Jeong A, Kimber TE, Klos K, Litvan I, O'Neill D, Robieson WZ, Spindler MA, Standaert DG, Talapala S, Vaou EO, Zheng H, Facheris MF, Hauser RA. Soileau MJ, et al. Among authors: klos k. Lancet Neurol. 2022 Dec;21(12):1099-1109. doi: 10.1016/S1474-4422(22)00400-8. Lancet Neurol. 2022. PMID: 36402160 Clinical Trial.
Brain metastases.
Klos KJ, O'Neill BP. Klos KJ, et al. Neurologist. 2004 Jan;10(1):31-46. doi: 10.1097/01.nrl.0000106922.83090.71. Neurologist. 2004. PMID: 14720313 Review.
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
McGarry A, Rosanbalm S, Leinonen M, Olanow CW, To D, Bell A, Lee D, Chang J, Dubow J, Dhall R, Burdick D, Parashos S, Feuerstein J, Quinn J, Pahwa R, Afshari M, Ramirez-Zamora A, Chou K, Tarakad A, Luca C, Klos K, Bordelon Y, St Hiliare MH, Shprecher D, Lee S, Dawson TM, Roschke V, Kieburtz K. McGarry A, et al. Among authors: klos k. Lancet Neurol. 2024 Jan;23(1):37-45. doi: 10.1016/S1474-4422(23)00378-2. Lancet Neurol. 2024. PMID: 38101901 Clinical Trial.
[Injuries of the peroneal tendons : Often overlooked].
Klos K, Knobe M, Randt T, Simons P, Mückley T. Klos K, et al. Unfallchirurg. 2017 Dec;120(12):1020-1030. doi: 10.1007/s00113-017-0398-y. Unfallchirurg. 2017. PMID: 28819784 Review. German.
Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial.
Camilleri M, Subramanian T, Pagan F, Isaacson S, Gil R, Hauser RA, Feldman M, Goldstein M, Kumar R, Truong D, Chhabria N, Walter BL, Eskenazi J, Riesenberg R, Burdick D, Tse W, Molho E, Robottom B, Bhatia P, Kadimi S, Klos K, Shprecher D, Marquez-Mendoza O, Hidalgo G, Grill S, Li G, Mandell H, Hughes M, Stephenson S, Vandersluis J, Pfeffer M, Duker A, Shivkumar V, Kinney W, MacDougall J, Zasloff M, Barbut D. Camilleri M, et al. Among authors: klos k. Ann Intern Med. 2022 Dec;175(12):1666-1674. doi: 10.7326/M22-1438. Epub 2022 Nov 8. Ann Intern Med. 2022. PMID: 36343348 Clinical Trial.
Quasi-planar InGaAsSb p-B-n photodiodes for spectroscopic sensing.
Hanks LA, Mamic K, Kłos K, Bainbridge A, Fletcher J, Gilder L, Tedstone L, Castaño FJ, Marshall ARJ. Hanks LA, et al. Among authors: klos k. Opt Express. 2023 Apr 24;31(9):14358-14366. doi: 10.1364/OE.485631. Opt Express. 2023. PMID: 37157301 Free article.
Neuropathology of non-motor features of Parkinson disease.
Dickson DW, Fujishiro H, Orr C, DelleDonne A, Josephs KA, Frigerio R, Burnett M, Parisi JE, Klos KJ, Ahlskog JE. Dickson DW, et al. Among authors: klos kj. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S1-5. doi: 10.1016/S1353-8020(09)70769-2. Parkinsonism Relat Disord. 2009. PMID: 20082965 Review.
208 results